Heart and brain - The influence of psychiatric disorders and their therapy on the heart rate variability;Herz und hirn - Die auswirkungen psychischer erkrankungen und ihrer therapie auf die herzfrequenzvariabilität

Fortschritte der Neurologie Psychiatrie

Volumn 73, Issue 4, 2005, Pages 192-205

  Birkhofer, A ^a   Schmidt, G ^a   Forstl H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ALZHEIMER DISEASE; ARTICLE; AUTONOMIC DYSFUNCTION; CHOLINERGIC ACTIVITY; CORONARY ARTERY DISEASE; DEATH; DISEASE SEVERITY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL PATIENT; MORTALITY; PANIC; PARAMETER; PATIENT MONITORING; PROGNOSIS; RISK FACTOR; SYMPATHETIC TONE; VAGUS TONE;

ALZHEIMER DISEASE; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER, MAJOR; HEART RATE; HUMANS; MENTAL DISORDERS; NONLINEAR DYNAMICS; PANIC DISORDER; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 17644414951     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830109     Document Type: Article

References (186)

1. Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003; 60: 627-636
2. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003; 290: 215-221
3. Lecrubier Y. The burden of depression and anxiety in general medicine. J Clin Psychiatry 2001; 62 (Suppl 8): 4-9; discussion 10-1:4-9
4. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003; 54: 216-226
5. Glassman AH, Bigger Jr JT. Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death. Am J Psychiatry 2001; 158: 1774-1782
6. Muck-Jorgensen P, Mors O, Mortensen PB, Ewald H. The schizophrenic patient in the somatic hospital. Acta Psychiatr Scand Suppl 2000; 102: 96-99
7. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065
8. Guo ZL, Li P, Longhurst JC. Central pathways in the pons and midbrain involved in cardiac sympathoexcitatory reflexes in cats. Neuroscience 2002; 113: 435-447
9. Verberne AJ, Owens NC. Cortical modulation of the cardiovascular system. Prog Neurobiol 1998; 54: 149-168
10. Ramage AG. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull 2001; 56: 425-439
11. Hilz MJ, Stemper B, Neundorfer B. [Physiology and methods for studying the baroreceptor reflex]. Fortschr Neurol Psychiatr 2000; 68: 37-47
12. Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol 2002; 282: H6-20
13. Barthel P, Schneider R, Bauer A, Ulm K, Schmitt C, Schomig A, Schmidt G. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 2003; 108: 1221-1226
14. Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger Jr JT, Schomig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999; 353: 1390-1396
15. Kleiger RE, Miller JP, Bigger Jr JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-262
16. Szabo BM, van Veldhuisen DJ, van der Veer V, Brouwer J, de Graeff PA, Crijns HJ. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1997; 79: 978-980
17. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998; 98: 1510-1516
18. Whitsel EA, Raghunathan TE, Pearce RM, Lin D, Rautaharju PM, Lemaitre R, Siscovick DS. RR interval variation, the QJ interval index and risk of primary cardiac arrest among patients without clinically recognized heart disease. Eur Heart J 2001; 22: 165-173
19. Malik M. Heart rate variability. Curr Opin Cardiol 1998; 13: 36-44
20. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-124
21. Ravenswaaij-Arts CM, Kollee LA, Hopman JC, Stoelinga GB, Geijn HP van. Heart rate variability. Ann Intern Med 1993; 118: 436-447
22. Tygesen H, Wettervik C, Claes G, Drott C, Emanuelsson H, Solem J, Lomsky M, Radberg G, Wennerblom B. Long-term effect of endoscopic transthoracic sympathicotomy on heart rate variability and QT dispersion in severe angina pectoris. Int J Cardiol 1999; 70: 283-292
23. Ewing DJ, Neilson JM, Shapiro CM, Stewart JA, Reid W. Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 1991; 65: 239-244
24. Maddens M, Lipsitz LA, Wei JY, Pluchino FC, Mark R. Impaired heart rate responses to cough and deep breathing in elderly patients with unexplained syncope. Am J Cardiol 1987; 60: 1368-1372
25. O'Brien IA, O'Hare P, Corrall RJ. Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 1986; 55: 348-354
26. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492
27. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-193
28. Cacioppo JT, Berntson GG, Binkley PF, Quigley KS, Uchino BN, Fieldstone A. Autonomic cardiac control. II. Noninvasive indices and basal response as revealed by autonomie blockades. Psychophysiology 1994; 31: 586-598
29. Lazzeri C, La Villa G, Mannelli M, Janni L, Franchi F. Effects of acute clonidine administration on power spectral analysis of heart rate variability in healthy humans. J Auton Pharmacol 1998; 18: 307-312
30. Brown TE, Beightol LA, Koh J, Eckberg DL. Important influence of respiration on human R-R interval power spectra is largely ignored. J Appl Physiol 1993; 75: 2310-2317
31. Kobayashi H, Ishibashi K, Noguchi H. Heart rate variability; an index for monitoring and analyzing human autonomie activities. Appl Human Sci 1999; 18: 53-59
32. Bacon SL, Watkins LL, Babyak M, Sherwood A, Hayano J, Hinderliter AL, Waugh R, Blumenthal JA. Effects of daily stress on autonomic cardiac control in patients with coronary artery disease. Am J Cardiol 2004; 93: 1292-1294
33. Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger Jr JT, Camm AJ, Schwartz PJ, Malik M. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am J Cardiol 2002; 89: 184-190
34. Huikuri HV, Kessler KM, Terracall E, Castellanos A, Linnaluoto MK, Myerburg RJ. Reproducibility and circadian rhythm of heart rate variability in healthy subjects. Am J Cardiol 1990; 65: 391-393
35. Kleiger RE, Bigger Jr JT, Bosner MS, Chung MK, Cook JR, Rolnitzky LM, Steinman R, Fleiss JL. Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol 1991; 68: 626-630
36. Kowalewski MA, Urban M. Short- and long-term reproducibility of autonomic measures in supine and standing positions. Clin Sci (Lond) 2004; 106: 61-66
37. Marks BL, Lightfoot JT. Reproducibility of resting heart rate variability with short sampling periods. Can J Appl Physiol 1999; 24: 337-348
38. Kautzner J, Camm AJ. Clinical relevance of heart rate variability. Clin Cardiol 1997; 20: 162-168
39. Smirne S, Ferini SL, Zucconi M, Pinto P, Franceschi M. Cardiac autonomic dysfunction during sleep in some neurological diseases. Neurophysiol Clin 1990; 20: 131-136
40. Ferrari AU, Radaelli A, Centola M. Invited review: aging and the cardiovascular system. J Appl Physiol 2003; 95: 2591-2597
41. Umetani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol 1998; 31: 593-601
42. Agelink MW, Baumann B, Sanner D, Kavuk I, Mueck-Weymann M. [Comorbidity between cardiovascular disease and affective illness]. Dtsch Med Wochenschr 2004; 129: 697-700
43. Keyes CL. The nexus of cardiovascular disease and depression revisited: the complete mental health perspective and the moderating role of age and gender. Aging Ment Health 2004; 8: 266-274
44. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002; 53: 897-902
45. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen Hosp Psychiatry 1996; 18: 61-65
46. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993; 95: 23-28
47. Januzzi Jr JL, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000; 160: 1913-1921
48. Zellweger MJ, Osterwalder RH, Langewitz W, Pfisterer ME. Coronary artery disease and depression. Eur Heart J 2004; 25: 3-9
49. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, Eijk JT van, Tilburg W van. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58: 221-227
50. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O'Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78: 613-617
51. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O'Connor C, Stone PH, Freedland KE. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024-2028
52. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270: 1819-1825
53. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005
54. Molgaard H, Sorensen KE, Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res 1991; 1: 233-237
55. Anda R, Williamson D, Jones D, Macera C, Eaker E, Classman A, Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993; 4: 285-294
56. Deuschle M, Lederbogen F. [Depression and cardiovascular disease: pathogenetic factors of the stress concept]. Fortschr Neurol Psychiatr 2002; 70: 268-275
57. Yeragani VK. Major depression and long-term heart period variability. Depress Anxiety 2000; 12: 51-52
58. Yeragani VK, Pesce V, Jayaraman A, Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol Psychiatry 2002; 52: 418-429
59. Glassman AH, Bigger Jr JT. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry 1981; 38: 815-820
60. Walsh BT, Greenhill LL, Giardina EG, Bigger JT, Waslick BD, Sloan RP, Bilich K, Wolk S, Bagiella E. Effects of desipramine on autonomic input to the heart. J Am Acad Child Adolesc Psychiatry 1999; 38: 1186-1192
61. Roose SP, Glassman AH, Attia E, Woodring S, Giardina EG, Bigger Jr JT. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998; 155: 660-665
62. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001; 104: 1894-1898
63. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger Jr JT, Krishnan KRR, Zyl LT van, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM for the Sertraline Antidepressant Heart Attack Randomized Trial Group. Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina. JAMA 2002; 288: 701-709
64. Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem 1999; 6: 469-480
65. Pacher P, Ungvari Z. Use of selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2002; 105: e84
66. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000; 62: 639-647
67. Writing Committee for the ENRICHD Investigators. Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106-3116
68. Rees K, Bennett P, West R, Davey SG, Ebrahim S. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2004; 2: CD002902
69. Dalack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990; 51 Suppl: 4-9
70. Balogh S, Fitzpatrick DF, Hendricks SE, Paige SR. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol Bull 1993; 29: 201-206
71. Rechlin T, Weis M, Spitzer A, Kaschka WP. Are affective disorders associated with alterations of heart rate variability? J Affect Disord 1994; 32: 271-275
72. Guinjoan SM, Bernabo JL, Cardinali DP. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. J Neurol Neurosurg Psychiatry 1995; 59: 299-302
73. Tulen JH, Bruijn JA, de Man KJ, van der Velden E, Pepplinkhuizen L, Man in't Veld AJ. Anxiety and autonomic regulation in major depressive disorder: an exploratory study. J Affect Disord 1996; 40: 61-71
74. Agelink MW, Boz C, Ullrich H, Andrich J. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res 2002; 113: 139-149
75. Yeragani VK, Rao KA, Smitha MR, Pohl RB, Balon R, Srinivasan K. Diminished chaos of heart rate time series in patients with major depression. Biol Psychiatry 2002; 51: 733-744
76. Moser M, Lehofer M, Hoehn-Saric R, McLeod DR, Hildebrandt G, Steinbrenner B, Voica M, Liebmann P, Zapotoczky HG. Increased heart rate in depressed subjects in spite of unchanged autonomic balance? J Affect Disord 1998; 48: 115-124
77. Agelink MW, Majewski T, Wurthmann C, Postert T, Linka T, Rotterdam S, Klieser E. Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. J Affect Disord 2001; 62: 187-198
78. Thayer JF, Smith M, Rossy LA, Sollers JJ, Friedman BH. Heart period variability and depressive symptoms: gender differences. Biol Psychiatry 1998; 44: 304-306
79. Hughes JW, Stoney CM. Depressed mood is related to high-frequency heart rate variability during Stressors. Psychosom Med 2000; 62: 796-803
80. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55: 580-592
81. Barefoot JC, Brummett BH, Helms MJ, Mark DB, Siegler IC, Williams RB. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 2000; 62: 790-795
82. Rechlin T. Decreased parameters of heart rate variation in amitriptyline treated patients: lower parameters in melancholic depression than in neurotic depression - a biological marker? Biol Psychiatry 1994; 36: 705-707
83. Stein PK, Carney RM, Freedland KE, Skala JA, Jaffe AS, Kleiger RE, Rottman JN. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 2000; 48: 493-500
84. Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, Glekas G, Koch GG, Sheps DS. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med 1997; 59: 231-235
85. Rechlin T, Weis M, Kaschka WP. Is diurnal variation of mood associated with parasympathetic activity? J Affect Disord 1995; 34: 249-255
86. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000; 108: 2-8
87. Kristensen E, Jakobsen J, Bartels U, Vestergaard P. Cholinergic dysfunction of heart, pupil, salivary glands, and urinary bladder in healthy volunteers during long-term treatment with clomipramine. Psychopharmacology (Berl) 1989; 98: 398-402
88. Jakobsen J, Hauksson P, Vestergaard P. Heart rate variation in patients treated with antidepressants. An index of anticholinergic effects? Psychopharmacology (Berl) 1984; 84: 544-548
89. Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994; 27: 124-128
90. Tulen JH, Bruijn JA, de Man KJ, Pepplinkhuizen L, Meiracker AH van den, Man in't Veld AJ. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 1996; 16: 135-145
91. Lederbogen F, Gernoth C, Weber B, Colla M, Kniest A, Heuser I, Deuschle M. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. J Clin Psychopharmacol 2001; 21: 238-239
92. Volkers AC, Tulen JH, Broek WW van den, Bruyn JA, Passchier J, Pepplinkhuizen L. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Pharmacopsychiatry 2004; 37: 18-25
93. Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol 1994; 14: 392-395
94. Shores MM, Pascualy M, Lewis NL, Flatness D, Veith RC. Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001; 26: 433-439
95. Pohl R, Balon R, Jayaraman A, Doll RG, Yeragani V. Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans. Journal of Psychosomatic Research 2003; 55: 247-251
96. Agelink MW, Ullrich H, Baumann B, Strum S, Majewski T. Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: preliminary data. Psychopharmacology (Berl) 2002; 163: 151-156
97. Khaykin Y, Dorian P, Baker B, Shapiro C, Sandor P, Mironov D, Irvine J, Newman D. Autonomic correlates of antidepressant treatment using heart-rate variability analysis . Can J Psychiatry 1998; 43: 183-186
98. Rechlin T, Weis M, Schneider K, Zimmermann U, Kaschka WP. Does bright-light therapy influence autonomic heart-rate parameters? J Affect Disord 1995; 34: 131-137
99. Rechlin T, Hegmann H, Weis M, Stemmler M, Claus D, Kaschka WP. Prediction of response to total sleep deprivation by autonomic heart rate parameters? Biol Psychiatry 1995; 37: 280-282
100. Agelink MW, Sanner D, Eich H, Fach J, Bertling R, Lemmer W, Klieser E, Lehmann E. [Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?]. Fortschr Neurol Psychiatr 2003; 71: 141-149
101. Schultz SK, Anderson EA, van de Borne P. Heart rate variability before and after treatment with electroconvulsive therapy. J Affect Disord 1997; 44: 13-20
102. Agelink MW, Malessa R, Kamcili E, Zeit T, Lemmer W, Bertling R, Klieser E. Cardiovascular autonomic reactivity in schizophrenics under neuroleptic treatment: A potential predictor of short-term outcome? Neuropsychobiology 1998; 38: 19-24
103. Roose SP, Glassman AH, Dalack GW. Depression, heart disease, and tricyclic antidepressants. J Clin Psychiatry 1989; 50 Suppl: 12-6; discussion 17.: 12-16
104. Nahshoni E, Aizenberg D, Sigler M, Zalsman G, Strasberg B, Imbar S, Weizman A. Heart rate variability in elderly patients before and after electroconvulsive therapy. Am J Geriatr Psychiatry 2001; 9: 255-260
105. Karpyak VM, Rasmussen KG, Hammill SC, Mrazek DA. Changes in heart rate variability in response to treatment with electroconvulsive therapy. J ECT 2004; 20: 81-88
106. Barlow DH. In: Anxiety and its Disorders. New York: Guilford, 1988
107. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994; 90: 2225-2229
108. Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn JP. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 1990; 147: 1504-1508
109. Haines A, Cooper J, Meade TW. Psychological characteristics and fatal ischaemic heart disease. Heart 2001; 85: 385-389
110. Thomas SA, Friedmann E, Wimbush F, Schron E. Psychological factors and survival in the cardiac arrhythmia suppression trial (CAST): a reexamination. Am J Crit Care 1997; 6: 116-126
111. Fleet R, Lavoie K, Beitman BD. Is panic disorder associated with coronary artery disease? A critical review of the literature. J Psychosom Res 2000; 48: 347-356
112. Friedman BH, Thayer JF, Borkovec TD, Tyrrell RA, Johnson BH, Columbo R. Autonomic characteristics of nonclinical panic and blood phobia. Biol Psychiatry 1993; 34: 298-310
113. Klein E, Cnaani E, Harel T, Braun S, Ben Haim SA. Altered heart rate variability in panic disorder patients. Biol Psychiatry 1995; 37: 18-24
114. Friedman BH, Thayer JF. Anxiety and autonomie flexibility: a cardiovascular approach. Biol Psychol 1998; 49: 303-323
115. Cohen H, Benjamin J, Geva AB, Matar MA, Kaplan Z, Kotler M. Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res 2000; 96: 1-13
116. Rechlin T. [The significance of heart rate analysis in psychiatric questions]. Fortschr Neurol Psychiatr 1995; 63: 106-120
117. Friedman BH, Thayer JF. Autonomic balance revisited: panic anxiety and heart rate variability. J Psychosom Res 1998; 44: 133-151
118. Yeragani VK, Srinivasan K, Balon R, Ramesh C, Berchou R. Lactate sensitivity and cardiac cholinergic function in panic disorder. Am J Psychiatry 1994; 151: 1226-1228
119. Asmundson GJ, Stein MB. Vagal attenuation in panic disorder: an assessment of parasympathetic nervous system function and subjective reactivity to respiratory manipulations. Psychosom Med 1994; 56: 187-193
120. Seier FE, Kellner M, Yassouridis A, Heese R, Strian F, Wiedemann K. Autonomic reactivity and hormonal secretion in lactate-induced panic attacks. Am J Physiol 1997; 272: H2630-H2638
121. Slaap BR, Nielen MM, Boshuisen ML, Roon AM van, Boer JA den. Five-minute recordings of heart rate variability in obsessive-compulsive disorder, panic disorder and healthy volunteers. J Affect Disord 2004; 78: 141-148
122. Ito T, Inoue Y, Sugihara T, Yamada H, Katayama S, Kawahara R. Autonomic function in the early stage of panic disorder: power spectral analysis of heart rate variability. Psychiatry Clin Neurosci 1999; 53: 667-672
123. Yeragani VK, Tancer M, Uhde T. Heart rate and QT interval variability: abnormal α-2 adrenergic function in patients with panic disorder. Psychiatry Res 2003; 121: 185-196
124. McCraty R, Atkinson M, Tomasino D, Stuppy WP. Analysis of twenty-four hour heart rate variability in patients with panic disorder. Biol Psychol 2001; 56: 131-150
125. Yeragani VK, Sobolewski E, Igel G, Johnson C, Jampala VC, Kay J, Hillman N, Yeragani S, Vempati S. Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records. Psychiatry Res 1998; 20; 78: 89-99
126. Srinivasan K, Ashok MV, Vaz M, Yeragani VK. Decreased chaos of heart rate time series in children of patients with panic disorder. Depress Anxiety 2002; 15: 159-167
127. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study). Am J Cardiol 1995; 75: 882-885
128. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992-1997
129. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) 1987; 295: 297-299
130. Thayer JF, Friedman BH, Borkovec TD. Autonomic characteristics of generalized anxiety disorder and worry. Biol Psychiatry 1996; 39: 255-266
131. Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, Klein DF, Gorman JM. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry 1997; 54: 643-648
132. Middleton HC. Cardiovascular dystonia in recovered panic patients. J Affect Disord 1990; 19: 229-236
133. Middleton HC, Ashby M. Clinical recovery from panic disorder is associated with evidence of changes in cardiovascular regulation. Acta Psychiatr Scand 1995; 91: 108-113
134. Tucker P, Adamson P, Miranda Jr R, Scarborough A, Williams D, Groff J, McLean H. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol 1997; 17: 370-376
135. Baker B, Khaykin Y, Devins G, Dorian P, Shapiro C, Newman D. Correlates of therapeutic response in panic disorder presenting with palpitations: heart rate variability, sleep, and placebo effect. Can J Psychiatry 2003; 48: 381-387
136. Slaap BR, Boshuisen ML, Roon AM van, Boer JA den. Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study. Int Clin Psychopharmacol 2002; 17: 69-74
137. Volz HP, Mackert A. [Cardiovascular irregularities in schizophrenia-more than an epiphenomenon?]. Nervenarzt 1991; 62: 298-302
138. Volz HP, Mackert A, Diefenbacher A, Friedrich A, Gaebel W, Muller H, Stock G, Moller HJ. Orthostatic challenge during neuroleptic test dose: a possible predictor of short-term outcome. Neuropsychobiology 1994; 30: 94-100
139. Dawson ME, Nuechterlein KH, Schell AM, Gitlin M, Ventura J. Autonomic abnormalities in schizophrenia. State or trait indicators? Arch Gen Psychiatry 1994; 51: 813-824
140. Nielsen BM, Mehlsen J, Behnke K. Altered balance in the autonomic nervous system in schizophrenic patients. Clin Physiol 1988; 8: 193-199
141. Olbrich R, Kirsch P, Pfeiffer H, Mussgay L. Patterns of recovery of autonomic dysfunctions and neurocognitive deficits in schizophrenics after acute psychotic episodes. J Abnorm Psychol 2001; 110: 142-150
142. Rechlin T, Claus D, Weis M. Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biol Psychiatry 1994; 35: 888-892
143. Valkonen-Korhonen M, Tarvainen MP, Ranta-Aho P, Karjalainen PA, Partanen J, Karhu J, Lehtonen J. Heart rate variability in acute psychosis. Psychophysiology 2003; 40: 716-726
144. Malaspina D, Bruder G, Dalack GW, Storer S, Kammen M van, Amador X, Glassman A, Gorman J. Diminished cardiac vagal tone in schizophrenia: associations to brain laterality and age of onset. Biol Psychiatry 1997; 41: 612-617
145. Kosky N. A possible association between high normal and high dose olanzapine and prolongation of the PR interval. J Psychopharmacol 2002; 16: 181-182
146. Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, Glasser DB, Morrison MF, Strom BL. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002; 325: 1070-1074
147. Appleby L, Thomas S, Ferrier N, Lewis G, Shaw J, Amos T. Sudden unexplained death in psychiatric in-patients. Br J Psychiatry 2000; 176: 405-406
148. Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, Palmer S, Browne C, Wallace C. Sudden death in psychiatric patients . Br J Psychiatry 1998; 172: 331-6: 331-336
149. Curkendall SM, Mo J, Glasser DB, Rose SM, Jones JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 2004; 65: 715-720
150. Chute D, Grove C, Rajasekhara B, Smialek JE. Schizophrenia and sudden death: a medical examiner case study. Am J Forensic Med Pathol 1999; 20: 131-135
151. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58: 1161-1167
152. Silke B, Campbell C, King DJ. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol 2002; 16: 355-360
153. Zahn TP, Pickar D. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. Biol Psychiatry 1993; 34: 3-12
154. Agelink MW, Majewski T, Wurthmann C, Lukas K, Ullrich H, Linka T, Klieser E. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001; 21: 8-13
155. Cohen H, Loewenthal U, Matar M, Kotler M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry 2001; 179: 167-171
156. Glassman AH. Clinical management of cardiovascular risks during treatment with psychotropic drugs. J Clin Psychiatry 2002; 63 Suppl 9: 12-17
157. Toichi M, Kubota Y, Murai T, Kamio Y, Sakihama M, Toriuchi T, Inakuma T, Sengoku A, Miyoshi K. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol 1999; 31: 147-154
158. Kim JH, Yi SH, Yoo CS, Yang SA, Yoon SC, Lee KY, Ahn YM, Kang UG, Kim YS. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 371-378
159. Rechlin T, Beck G, Weis M, Kaschka WP. Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients. Psychopharmacology (Berl) 1998; 135: 338-341
160. Eschweiler GW, Bartels M, Langle G, Wild B, Gaertner I, Nickola M. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine? Pharmacopsychiatry 2002; 35: 96-100
161. Ballard CG, Shaw F, Lowery K, McKeith I, Kenny R. The Prevalence, Assessment and Associations of Falls in Dementia with Lewy Bodies and Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders 1999; 10: 97-103
162. Horimoto Y, Matsumoto M, Akatsu H, Ikari H, Kojima K, Yamamoto T, Otsuka Y, Ojika K, Ueda R, Kosaka K. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol 2003; 250: 530-533
163. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701-1707
164. Dijk PT van, Meulenberg OG, Sande HJ van de, Habbema JD. Falls in dementia patients. Gerontologist 1993; 33: 200-204
165. Davies AJ, Kenny RA. Falls presenting to the accident and emergency department: types of presentation and risk factor profile. Age Ageing 1996; 25: 362-366
166. McIntosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardioinhibitory, and mixed carotid sinus syndrome in the elderly. Am J Med 1993; 95: 203-208
167. Richardson DA, Bexton RS, Shaw FE, Kenny RA. Prevalence of cardioinhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the accident and emergency department with "unexplained" or "recurrent" falls. Pacing Clin Electrophysiol 1997; 20: 820-823
168. Calvo-Romero JM, Ramos-Salado JL. [Symptomatic sinus bradycardia associated with donepezil]. Rev Neurol 1999; 28: 1070-1072
169. Kenny RA, Kalaria R, Ballard C. Neurocardiovascular instability in cognitive impairment and dementia. Ann N Y Acad Sci 2002; 977: 183-195
170. Morganroth J, Graham S, Hartman R, Anand R. Electrocardiographic effects of rivastigmine. J Clin Pharmacol 2002; 42: 558-568
171. Dunn NR, Pearce GL, Shakir SA. Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol 2000; 14: 406-408
172. Pratt RD, Perdomo CA, Surick IW, Ieni JR. Donepezil: tolerability and safety in Alzheimer's disease. Int J Clin Pract 2002; 56: 710-717
173. Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B. Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group. Neurology 1998; 50: 1214-1221
174. Szili-Torok T, Kaiman J, Paprika D, Dibo G, Rozsa Z, Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer's and Parkinson's disease. Neurobiol Aging 2001; 22: 435-438
175. Aharon-Peretz J, Harel T, Revach M, Ben Haim SA. Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease. Arch Neurol 1992; 49: 919-922
176. Algotsson A, Viitanen M, Winblad B, Solders G. Autonomic dysfunction in Alzheimer's disease. Acta Neurol Scand 1995; 91: 14-18
177. Giubilei F, Strano S, Imbimbo BP, Tisei P, Calcagnini G, Lino S, Frontoni M, Santini M, Fieschi C. Cardiac autonomic dysfunction in patients with Alzheimer disease: possible pathogenetic mechanisms. Alzheimer Dis Assoc Disord 1998; 12: 356-361
178. Idiaquez J, Sandoval E. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 1999; 53: 1610
179. Murakami S, Yamanaka T, Kubo Y, Wada T, Yano S, Nishimura Y, Shinagawa M, Matsubayashi K, Otsuka K, Ohkawa S, Kawata H. [Heart rate variability analysis and neurobehavioral function in community-dwelling older people aged 75 or older]. Nippon Ronen Igakkai Zasshi 2002; 39: 520-526
180. McLaren AT, Allen J, Murray A, Ballard CG, Kenny RA. Cardiovascular effects of donepezil in patients with dementia. Dement Geriatr Cogn Disord 2003; 15: 183-188
181. Masuda Y, Kawamura A. Acetylcholinesterase inhibitor (donepezil hydrochloride) reduces heart rate variability. J Cardiovasc Pharmacol 2003; 41 Suppl 1: S67-S71
182. Stampfer HG. The relationship between psychiatric illness and the circadian pattern of heart rate. Aust N Z J Psychiatry 1998; 32: 187-198
183. Bigger Jr JT, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR Variability in Healthy, Middle-Aged Persons Compared With Patients With Chronic Coronary Heart Disease or Recent Acute Myocardial Infarction. Circulation 1995; 91: 1936-1943
184. Serrador JM, Finlayson HC, Hughson RL. Physical activity is a major contributor to the ultra low frequency components of heart rate variability. Heart 1999; 82: e9
185. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Jung I, Sherwood P. Heart rate variability in patients with major depression. Psychiatry Res 1991; 37: 35-46
186. Rechlin T, Claus D, Weis M. Heart rate analysis in 24 patients treated with 150 mg amitriptyline per day. Psychopharmacology (Berl) 1994; 116: 110-114